Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania.
Despitevery similar political, drug policy and HIV prevention backgrounds, HIV and HCV prevalence is considerably different in Hungary (low HIV and moderate HCV prevalence) and Lithuania (high HCV and moderate HIV prevalence). Wecompared the drug use profile of Hungarian (n = 215) and Lithuanian (n = 300) injecting drug users (IDUs). Overall, compared with IDUs in Hungary, IDUs in Lithuania often injected opiates purchased in liquid form ('shirka'), used and shared 2-piece syringes (vs. 1-piece syringes) disproportionately more often, were less likely to acquire their syringes from legal sources and had significantly more experience with injected and less experience with non-injected drugs. It may not be liquid drugs per se that contribute to a higher prevalence of HCV and/or HIV, but it is probably factors associated with the injecting of liquid drugs, such as the wide-spread use and sharing of potentially contaminated 2-piece syringes acquired often from non-legal sources, and syringe-mediated drug sharing with 2-piece syringes. Scaling up substitution therapy, especially heroin replacement, combined with reducing the supply of liquid drugs may decrease the prevalence of high-risk injecting behaviours related to the injecting of liquid drugs and drug injecting-related infections among IDUs in Lithuania.
Gyarmathy
V Anna
VA
European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal. anna.gyarmathy@emcdda.europa.eu
Neaigus
Alan
A
Li
Nan
N
Ujhelyi
Eszter
E
Caplinskiene
Irma
I
Caplinskas
Saulius
S
Latkin
Carl A
CA
D000328:Adult; D016009:Chi-Square Distribution; D055030:Drug Users; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D007407:Interviews as Topic; D008097:Lithuania / Q000453:epidemiology; D008297:Male; D015999:Multivariate Analysis; D016485:Needle Sharing; D018671:Needle-Exchange Programs; D015995:Prevalence; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000453:epidemiology*
J Clin Microbiol. 2005 Apr;43(4):1937-9
15815025
AIDS Care. 2007 Jan;19(1):59-66
17129858
Subst Use Misuse. 2001 Jan;36(1-2):71-89
11305355
Addiction. 2006 May;101(5):731-7
16669907
Soc Sci Med. 2003 Jul;57(1):39-54
12753815
J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):82-8
14707797
Eur J Public Health. 2001 Dec;11(4):425-30
11766485
J Urban Health. 2003 Jun;80(2):330-48
12791808
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):294-5
9117464
Soc Sci Med. 2004 Jul;59(1):113-27
15087148
Drug Alcohol Depend. 2009 Mar 1;100(3):204-13
19004579
J Psychoactive Drugs. 2003 Oct-Dec;35(4):419-26
14986870
Drug Alcohol Depend. 2003 Jun 5;70(3):275-86
12757965
Drug Alcohol Depend. 2009 Mar 1;100(3):240-7
19058925
AIDS. 2001 Apr;15 Suppl 3:S49-59
11421183
Br J Psychiatry. 2007 Jul;191:55-62
17602126
J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):493-503
16652059
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S65-9
16769448
Addiction. 2008 Jun;103(6):960-6; discussion 967-8
18422829
BMC Infect Dis. 2009 Feb 09;9:14
19203380
Soc Sci Med. 2002 Oct;55(7):1103-13
12365524